Andrew Joe

Andrew Joe

Chief Tech/Sci/R&D Officer at MERUS N.V.

Net worth: - $ as of 2024-03-30

58 year
Finance
Consumer Services
Health Technology

Network origin in Andrew Joe first degree

EntityEntity typeIndustry
Public Company Biotechnology 20

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Andrew Joe via their personal network

CompanySectorRelated peopleMain position
Pharmaceuticals: Major

Bill Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

Len Kanavy

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Bill Lundberg

Corporate Officer/Principal

Rochester Christian University College/University

Peter Silverman

Undergraduate Degree

Medical Specialties

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Antisoma Research Ltd.

Bill Lundberg

Corporate Officer/Principal

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

KALA BIO, INC. Pharmaceuticals: Major

Gregory Perry

Mark Iwicki

Director/Board Member

Chief Executive Officer

Biotechnology

Mark Iwicki

Director/Board Member

ACLARIS THERAPEUTICS, INC. Pharmaceuticals: Major

Maxine Gowen

Anand Mehra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Miscellaneous Commercial Services

Peter Silverman

Corporate Officer/Principal

Investment Managers

Mark Iwicki

Consultant / Advisor

College/University

Mark Throsby

Doctorate Degree

College/University

Sherri L. Spear

Undergraduate Degree

Loyola University Maryland, Inc. College/University

Mark Iwicki

Masters Business Admin

University of Michigan College/University

Liu Hui

Doctorate Degree

University of Scranton College/University

Len Kanavy

Masters Business Admin

Pharmaceuticals: Major

Mark Iwicki

Corporate Officer/Principal

University of Utrecht College/University

John de Kruif

Cecilia Anna Wilhelmina Geuijen

Doctorate Degree

Doctorate Degree

Investment Banks/Brokers

Sherri L. Spear

Analyst-Equity

Stanford University School of Medicine College/University

Bill Lundberg

Doctorate Degree

Fordham University School of Law College/University

Peter Silverman

Graduate Degree

CRISPR THERAPEUTICS AG Biotechnology

Bill Lundberg

Chief Tech/Sci/R&D Officer

PULMATRIX, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Biotechnology

Mark Iwicki

Bill Lundberg

Chairman

Director/Board Member

Miscellaneous Commercial Services

Mark Throsby

Chief Executive Officer

Pharmaceuticals: Major

Mark Throsby

Director/Board Member

Medical Specialties

Mark Throsby

Chief Operating Officer

THIRD HARMONIC BIO, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

AEROVATE THERAPEUTICS, INC. Biotechnology

Mark Iwicki

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

RALLYBIO CORPORATION Biotechnology

Liu Hui

Director/Board Member

Pharmaceuticals: Major

Len Kanavy

Corporate Officer/Principal

Genentech Access To Care Foundation

Len Kanavy

Director/Board Member

Statistics

International

United States 37
Netherlands 5
United Kingdom 4
Australia 2
Switzerland 2

Sectoral

Health Technology 26
Consumer Services 10
Finance 7
Commercial Services 5

Operational

Director/Board Member 72
Corporate Officer/Principal 37
Independent Dir/Board Member 37
Director of Finance/CFO 12
Doctorate Degree 11
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW